Objective: To address a significant gap in research and clinical practice by developing the global conceptual definition of Sarcopenia. Methodology: Study design; Two-phase Delphi study with participants from leading international musculoskeletal organisations and sarcopenia societies [1]. A steering committee was formed of representatives from each continent/region (Asia, Europe, North America, South America, New Zealand/Australia). The steering committee then developed a glossary of research terms on sarcopenia [2]. Following this, a list of statements on critical aspects of sarcopenia was developed and finalised. Participants: Invitations to complete an online survey were sent to international experts from academic, industry, and healthcare professions. All participants including steering committee members completed a declaration of interest form prior to participation. Statistical analysis: Prespecified criteria were set by the steering committee including a two-phase study design and an acceptable threshold of > 80% for accepted statements

An executive summary on the Global conceptual definition of Sarcopenia / Kirk, Ben; Cawthon, Peggy M.; Arai, Hidenori; Ávila-Funes, José A.; Barazzoni, Rocco; Bhasin, Shalender; Binder, Ellen F.; Bruyère, Olivier; Cederholm, Tommy; Chen, Liang-Kung; Cooper, Cyrus; Duque, Gustavo; Fielding, Roger A.; Guralnik, Jack; Kiel, Douglas P.; Landi, Francesco; Reginster, Jean-Yves; Sayer, Avan A.; Visser, Marjolein; von Haehling, Stephan; Woo, Jean; Cruz-Jentoft, Alfonso J.; Global Leadership Initiative in Sarcopenia (GLIS), Group. - In: AGING CLINICAL AND EXPERIMENTAL RESEARCH. - ISSN 1720-8319. - ELETTRONICO. - 36:1(2024), pp. 153."-"-153."-". [10.1007/s40520-024-02798-4]

An executive summary on the Global conceptual definition of Sarcopenia

Barazzoni, Rocco;
2024-01-01

Abstract

Objective: To address a significant gap in research and clinical practice by developing the global conceptual definition of Sarcopenia. Methodology: Study design; Two-phase Delphi study with participants from leading international musculoskeletal organisations and sarcopenia societies [1]. A steering committee was formed of representatives from each continent/region (Asia, Europe, North America, South America, New Zealand/Australia). The steering committee then developed a glossary of research terms on sarcopenia [2]. Following this, a list of statements on critical aspects of sarcopenia was developed and finalised. Participants: Invitations to complete an online survey were sent to international experts from academic, industry, and healthcare professions. All participants including steering committee members completed a declaration of interest form prior to participation. Statistical analysis: Prespecified criteria were set by the steering committee including a two-phase study design and an acceptable threshold of > 80% for accepted statements
File in questo prodotto:
File Dimensione Formato  
2024 Kirk.pdf

accesso aperto

Tipologia: Documento in Versione Editoriale
Licenza: Creative commons
Dimensione 665.43 kB
Formato Adobe PDF
665.43 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11368/3096767
Citazioni
  • ???jsp.display-item.citation.pmc??? 7
  • Scopus 11
  • ???jsp.display-item.citation.isi??? 9
social impact